Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B H Xu

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 11, 2012
Docetaxel-cisplatin might be superior to docetaxel-capecitabine in the first-line treatment of metastatic triple-negative breast cancerY Fan, B H Xu, P Yuan, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|January 26, 2026
[The clinical efficacy of unilateral biportal endoscopy contralateral inclinatory approach in the treatment of lumbar foraminal stenosis]B H Xu, B Zhu, H Y Yu, et al.
International Journal of Cancer|November 3, 1995
Modulation of cisplatin sensitivity and accumulation by interferon alpha-2A in human squamous carcinoma cell linesV Gupta, J P Jani, E O Emerson, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|June 21, 2019
[The clinical reports on adrenal insufficiency of patients with advanced solid tumors accepting anti-PD-1 antibody, SHR-1210 therapy]J L Tang, J Huang, X Wang, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Activity of melphalan in combination with the glutathione transferase inhibitor sulfasalazineV Gupta, J P Jani, S Jacobs, et al.
ESMO Open|September 6, 2024
QL1701 (a proposed trastuzumab biosimilar) versus reference trastuzumab plus docetaxel as first-line therapy for HER2-positive metastatic breast cancer: a multicenter, randomized, double-blinded, parallel-controlled, phase III equivalence trialQ-Y Zhang, R-G Cai, G-H Song, et al.
International Journal of Cancer|May 4, 1995
Mechanism of cross-resistance to cisplatin in a mitomycin C-resistant human bladder cancer cell lineS V Singh, B H Xu, J P Jani, et al.
Genetics and Molecular Research : GMR|May 14, 2016
Characterization of grass carp spleen transcriptome during GCRV infectionB H Xu, L Zhong, Q L Liu, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|March 14, 2019
[Genetic variation in DNA polymerase kappa gene is associated with the prognosis after platinum-based chemotherapy in small cell lung cancer patients]J N Chen, T Feng, J Yang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|June 3, 2020
[An investigation of the fertility needs of young patients with breast cancer]J Ju, L X Zhang, J Yue, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 11, 2012
Docetaxel-cisplatin might be superior to docetaxel-capecitabine in the first-line treatment of metastatic triple-negative breast cancerY Fan, B H Xu, P Yuan, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|January 26, 2026
[The clinical efficacy of unilateral biportal endoscopy contralateral inclinatory approach in the treatment of lumbar foraminal stenosis]B H Xu, B Zhu, H Y Yu, et al.
International Journal of Cancer|November 3, 1995
Modulation of cisplatin sensitivity and accumulation by interferon alpha-2A in human squamous carcinoma cell linesV Gupta, J P Jani, E O Emerson, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|June 21, 2019
[The clinical reports on adrenal insufficiency of patients with advanced solid tumors accepting anti-PD-1 antibody, SHR-1210 therapy]J L Tang, J Huang, X Wang, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Activity of melphalan in combination with the glutathione transferase inhibitor sulfasalazineV Gupta, J P Jani, S Jacobs, et al.
ESMO Open|September 6, 2024
QL1701 (a proposed trastuzumab biosimilar) versus reference trastuzumab plus docetaxel as first-line therapy for HER2-positive metastatic breast cancer: a multicenter, randomized, double-blinded, parallel-controlled, phase III equivalence trialQ-Y Zhang, R-G Cai, G-H Song, et al.
International Journal of Cancer|May 4, 1995
Mechanism of cross-resistance to cisplatin in a mitomycin C-resistant human bladder cancer cell lineS V Singh, B H Xu, J P Jani, et al.
Genetics and Molecular Research : GMR|May 14, 2016
Characterization of grass carp spleen transcriptome during GCRV infectionB H Xu, L Zhong, Q L Liu, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|March 14, 2019
[Genetic variation in DNA polymerase kappa gene is associated with the prognosis after platinum-based chemotherapy in small cell lung cancer patients]J N Chen, T Feng, J Yang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|June 3, 2020
[An investigation of the fertility needs of young patients with breast cancer]J Ju, L X Zhang, J Yue, et al.
Pageof 7